中伦助力臻亿医疗完成C轮融资

Core Insights - Jiangsu Zhenyi Medical Technology Co., Ltd. has completed a C-round financing of several hundred million yuan, indicating strong market recognition of its platform-based layout and technological innovation capabilities [2][6][7] - The financing round was led by multiple investors including Dongfang Fuhai, Guoyuan Equity, and others, with existing shareholder Life Tree Capital also increasing its stake [2][6] - Zhenyi Medical focuses on the high-mortality cardiovascular disease sector, which remains largely untapped in the domestic market, and aims to provide innovative solutions for blood flow management [2][6] Company Overview - Established in 2019, Zhenyi Medical has rapidly emerged as a significant player in China's high-end medical device industry, covering various interventional treatment areas such as heart valves, peripheral, and coronary interventions [2][6] - The company has maintained a high growth rate, accelerating its research, registration, and clinical progress following the completion of its B+ round financing in 2023 [6][7] - The successful C-round financing supports the company's transition into a scalable commercial phase and international expansion [2][6][7] Legal Support - Zhonglun Law Firm provided comprehensive legal services for Zhenyi Medical's financing, including drafting and modifying transaction documents, business negotiations, and assisting with the closing [3][7]